Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management

Underreporting tuberculosis (TB) cases can compromise surveillance. We evaluated the contribution of pharmacy data in three different managed-care settings and geographic areas. Persons with more than two anti-TB medications were identified by using pharmacy databases. Active TB was confirmed by usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoe, Deborah S., Coon, Steven W., Dokholyan, Rachel, Iannuzzi, Michael C., Jones, Timothy F., Meredith, Sarah, Moore, Marisa, Phillips, Lynelle, Ray, Wayne, Schech, Stephanie, Shatin, Deborah, Platt, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320428/
https://www.ncbi.nlm.nih.gov/pubmed/15496244
http://dx.doi.org/10.3201/eid1008.031075
Descripción
Sumario:Underreporting tuberculosis (TB) cases can compromise surveillance. We evaluated the contribution of pharmacy data in three different managed-care settings and geographic areas. Persons with more than two anti-TB medications were identified by using pharmacy databases. Active TB was confirmed by using state TB registries, medical record review, or questionnaires from prescribing physicians. We identified 207 active TB cases, including 13 (6%) missed by traditional surveillance. Pharmacy screening identified 80% of persons with TB who had received their medications through health plan–reimbursed sources, but missed those treated solely in public health clinics. The positive predictive value of receiving more than two anti-TB medications was 33%. Pharmacy data also provided useful information about physicians' management of TB and patients' adherence to prescribed therapy. Pharmacy data can help public health officials to find TB cases and assess their management in populations that receive care in the private sector.

Ejemplares similares